The regenerative medicine market is projected to reach $40.6 billion by 2027 from $12.2 billion in 2022, at a CAGR of 27.2%.
during the forecast period. Market growth is driven by the availability of funds and increased investments in R&D, increased clinical trials for stem cell and CAR-T cell therapies, and increasing advances in tissue-engineered products.
New York, Dec. 26, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Regenerative Medicine Market By Product, Gene Therapy, Tissue Engineering, Application, Region – Global Forecast to 2027” – https://www.reportlinker.com/p04700208/?utm_source=GNW
However, the high cost of MRI therapy treatment and commercialization and regulation are expected to restrict market growth during the forecast period.
By application, the musculoskeletal disorders segment accounted for the largest share of the regenerative medicine market.
Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, eye disorders, dental disorders, and other applications. In 2021, the musculoskeletal disorders segment accounted for the largest market share.
This can be attributed to the increasing prevalence of orthopedic diseases, the growing geriatric population, the increasing number of stem cell research projects, the increasing number of clinical investigations/trials, and the rich portfolio of stem cell products for the treatment of disorders. musculoskeletal.
Asia Pacific: The fastest growing region in the regenerative medicine market.
The Asia Pacific market is anticipated to grow at the highest CAGR during the forecast period, mainly due to increased research activities in Asian countries, the availability of research funds, and the increasing number of biobanks and research centers. research driving growth in Asia. Pacific regenerative medicine market.
North America: Majority of the Regenerative Medicine Market
North America accounted for the largest share of the regenerative medicine market. Factors such as the establishment of stem cell banks, tissue engineering, increased demand for treatments based on advanced technology such as stem cell technology, biologics, tissue engineering, and biomaterials.
The main interviews conducted for this report can be classified as follows:
• Per respondent: supply side: 80% and demand side: 20%
• By Designation: Level C – 25%, Level D – 20% and Others – 55%
• By region: North America -50%, Europe -20%, Asia-Pacific -20%, Latin America -5%, Middle East and Africa: 5%
Principal actors
• Novartis AG (Switzerland)
• Biogen (USA)
• Sarepta Therapeutics, Inc. (USA)
• Gilead Sciences, Inc. (USA)
• Amgen, Inc. (USA)
• Smith & Nephew plc (United Kingdom)
• MEDIPOST Co., Ltd. (South Korea)
• JCR Pharmaceuticals Co., Ltd (Japan)
• Takeda Pharmaceutical Company (Japan)
• CORESTEM Inc (South Korea)
• Vericel Corporation (USA)
• MIMEDX (USA)
• Organogenesis Inc. (USA)
• Medtronic plc (USA)
• Orthocell Ltd. (Australia)
• Mesoblast Ltd (Australia)
• BioRestorative Therapies (USA)
• More Inc, (Israel)
• Tegociencia (South Korea)
• Antegen Co., Ltd. (South Korea)
• Bluebird Bio (USA)
• Biotechnology APAC (India)
• Shenzhen Sibiono Genetech Co., Ltd. Porcelain
• Aspect Biosystems (Canada)
• Athersys, Inc. (USA)
Research coverage:
This report provides a detailed picture of the regenerative medicine market. Its goal is to estimate the size and future growth potential of the market in different segments such as product, applications, and region.
The report also includes in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key benefits of purchasing the report:
The report will assist market leaders/new entrants by providing the closest approximations to revenue numbers for the overall regenerative medicine market and its segments. It will also help stakeholders to better understand the competitive landscape and gain more information to better position their business and make appropriate go-to-market strategies.
This report will enable stakeholders to understand the pulse of the market and provide them with insights into the key market drivers, restraints, trends, opportunities, and challenges.
Read the full report: https://www.reportlinker.com/p04700208/?utm_source=GNW
On reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need, instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
